US4894150A - Mechanical device for simplifying fluid balance in hemofiltration - Google Patents
Mechanical device for simplifying fluid balance in hemofiltration Download PDFInfo
- Publication number
- US4894150A US4894150A US07/205,618 US20561888A US4894150A US 4894150 A US4894150 A US 4894150A US 20561888 A US20561888 A US 20561888A US 4894150 A US4894150 A US 4894150A
- Authority
- US
- United States
- Prior art keywords
- filtrate
- reservoir
- source
- substitution
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 84
- 238000002615 hemofiltration Methods 0.000 title description 28
- 239000000706 filtrate Substances 0.000 claims abstract description 82
- 238000006467 substitution reaction Methods 0.000 claims abstract description 75
- 230000004044 response Effects 0.000 claims abstract description 9
- 238000001802 infusion Methods 0.000 claims description 13
- 239000002699 waste material Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 11
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 12
- 230000003213 activating effect Effects 0.000 claims 2
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 238000000034 method Methods 0.000 description 19
- 238000011282 treatment Methods 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000001631 haemodialysis Methods 0.000 description 9
- 230000000322 hemodialysis Effects 0.000 description 9
- 208000009304 Acute Kidney Injury Diseases 0.000 description 5
- 208000033626 Renal failure acute Diseases 0.000 description 5
- 201000011040 acute kidney failure Diseases 0.000 description 5
- 208000012998 acute renal failure Diseases 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 208000034486 Multi-organ failure Diseases 0.000 description 2
- 208000010718 Multiple Organ Failure Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 206010001526 Air embolism Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229910000639 Spring steel Inorganic materials 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007485 conventional hemodialysis Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000011316 hemodynamic instability Diseases 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- -1 i.e. Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
- A61M1/3451—Substitution rate control as a function of the ultrafiltration rate the difference in weight between both ultra-filtrate and substitution reservoir being used as control signal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
- A61M2209/082—Mounting brackets, arm supports for equipment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S210/00—Liquid purification or separation
- Y10S210/929—Hemoultrafiltrate volume measurement or control processes
Definitions
- the present invention relates to a mechanical device for simplifying fluid balance in a filtration system, particularly a continuous arterio-venous hemofiltration (CAVH) system.
- Continuous arteriovenous hemofiltration (CAVH) has become a valuable tool in the treatment of acute renal failure in critically ill patients.
- hemodialysis In patients experiencing acute or chronic renal failure, the elimination of excess water and waste products is conventionally performed by hemodialysis. This mode of treatment is quite different from the function of natural kidneys. Hemodialysis utilizes relatively high cost, technically sophisticated, electronically controlled machines to effect this process. Connections to electricity and to pure water (deionized water or reverse osmosis water) are necessary. Moreover, association with a regular technical service is required and the procedure must be performed by specialized nurses and physicians. A standard hemodialysis treatment regimen is 3X5 hours during one week. As excess water and waste products are eliminated quite rapidly during the short treatment periods, hemodynamic instability is a common side effect. The same is generally true for mechanical hemofiltration, although there are differences in quantity.
- a recently developed mode of treating patients who have acute renal failure is with continuous arterio-venous hemofiltration This treatment is directed primarily to patients who are immobilized and must be treated using a mechanical respiratory assist. By the use of this mode of treatment, some of the disadvantages of conventional therapy can be eliminated and the attendant costs reduced.
- a small capillary hemofilter In continuous arterio-venous hemofiltration, a small capillary hemofilter is connected to both a patient's artery and vein to provide access to the patient's blood.
- the filter capillaries are permeable to water and non-protein bound substances up to a molecular weight of 10000 to 50000 daltons. Blood cells and protein, however, remain within the blood compartment. This treatment is intended to simulate the function of the patient's kidneys. Filtration is driven by the patients circulation without the necessity for an extracorporeal pump. Only 1 to 2% of the patient's circulation is used for this extracorporeal circulation.
- CAVH continuous arteriovenous hemofiltration
- Another object of the invention is to provide a method and a device which permit automatic fluid balance to be achieved without having to resort to manual procedures.
- An additional object of the invention is to provide a method and a device which alleviate the medical and economic disadvantages of conventional hemodialysis treatments.
- a further object of the invention is to provide a method and a device which can be used by the intensive care staff of a hospital with minimum training.
- One aspect of the invention resides in a device for equalizing the rate of flow of substitution fluid and the rate of flow of filtrate in a filtration system, particularly a continuous arterio-venous hemofiltration system, where a waste-enriched fluid, e.g., a fluid enriched in metabolic wastes, is passed through a filter, a portion of the waste-enriched fluid is removed as filtrate, and the removed portion of the waste-enriched fluid is at least partially replaced by a substitution fluid.
- a waste-enriched fluid e.g., a fluid enriched in metabolic wastes
- a mechanical balancing system designed to support a source of the substitution fluid at a first level above the filter, and to support a reservoir for the filtrate at a second level below the filter.
- the balancing system is arranged to undergo deflection in response to a difference between an instantaneous equilibrium force and the instantaneous total weight of fluid in the source and the reservoir.
- a control unit for regulating the rate of flow of the substitution fluid from the source.
- a mechanical linkage designed to transmit motion between the balancing system and the control unit in such a manner that the control unit changes the flow rate of the substitution fluid from the source in response to deflection of the balancing system.
- the balancing system includes a vertical stand having two mechanically coupled, horizontal cross beams mounted on roller bearings.
- the beams are disposed at different levels, and a source or bag of substitution fluid, e.g., a 4.5 liter bag, suspended from one side of the upper beam, e.g., approximately 2 meters above the ground, is counterbalanced by a weight on the opposite side.
- a source or bag of substitution fluid e.g., a 4.5 liter bag
- filtrate is introduced into a reservoir or container suspended from the lower beam below the bag of substitution fluid, a growing imbalance arises and causes opening of a control unit or tube clamp which mechanically sets the fluid substitution rate to the rate of filtration with a high degree of accuracy, e.g., ⁇ 10 ml/4.5 liter exchange.
- the lower beam may, for example, be mounted at a height of 76 cm above the ground while the container, e.g., of 10 liter capacity, is then suspended at a height of 42 cm.
- the container e.g., of 10 liter capacity
- Setting the level of the upper beam at 2 meters above the floor guarantees a hydrostatic pressure sufficiently high to enable substitution to occur even through an extra filter system.
- the tube clamp may be constructed of a tube holding block in which a flexible tube segment (e.g., a silastic tube which is integrated into the infusion line) is suspended.
- a movable pin for tube clamping is mechanically coupled to a coupling bar serving to join the beams.
- the set point of the automatic balancing system may be adjusted by an extra weight, e.g., a 650 g weight, movable along a screw constituting a prolongation of the lower beam. This permits exact adjustment of the system to compensate for small differences in the weights of the substitution fluid bags delivered by different suppliers.
- another component may be added.
- This may take the form of a graduated container, e.g., of 2 liter capacity, which is suspended on the same side as the counterweight and is partially filled with fluid at the end of a cycle.
- the graduated container may be gradually and continuously filled during an exchange using a drip infusion unit. The infusion rate then determines the negative balance.
- the graduated container may be filled prior to an exchange. If, for example, a negative balance of 2 liters is required for a 4.5 liter exchange, the graduated container is filled with 2 liters of fluid and, at the end of the exchange run, the filtrate container has 6.5 liters of fluid to balance the 4.5 liters of substitution fluid and the 2 liters of negative balance fluid.
- a negative balance may also be achieved by providing one of the beams with means for positioning the substitution fluid bag or the filtrate container at any of a plurality of preselected locations along the respective beam.
- the positioning means may, for instance, be designed in such a manner that the negative balance can be adjusted in steps of 0.5 liter.
- the positioning means is formed on the lower beam which supports the filtrate container.
- the positioning means may, for example, take the form of notches.
- the balancing system includes a first frame, and a second frame which at least partly surrounds the first frame.
- One of the frames carries the other of the frames and is capable of being suspended, e.g., from a ceiling. It is preferred for the second or outer frame to carry the first or inner frame.
- the inner frame is then shiftable relative to the outer frame and is designed to support both the substitution fluid bag and the filtrate container.
- a biasing element may be disposed between the frames and functions as a counterweight.
- the control unit which may again be in the form of a tube clamp, here regulates the rate of flow of substitution fluid from the bag in response to relative movements of the frames. Preferably, these relative movements are transmitted to the tube clamp via a scissors-like lever arrangement.
- a shut-off unit may be provided to automatically terminate the flow of filtrate to the filtrate container once emptying of the substitution fluid bag has occurred.
- the shut-off unit may, for instance, take the form of a tube clamp which is caused to pinch the tube or hose leading from the filter to the filtrate container after the substitution fluid bag is empty.
- the tube clamp is advantageously activated by one of the beams, preferably the lower beam which supports the filtrate container.
- Another aspect of the invention resides in a filtering method, particularly for use in continuous arterio-venous hemofiltration, which comprises the following steps:
- the withdrawing and admitting step is performed at least in part gravitationally and without passing the filtrate through a pump.
- a recurrent problem in continuous arterio-venous hemofiltration was the manual handling of a daily fluid exchange of between 12 and 20 liters.
- substitution bags and containers need only be changed once during each nursing shift (i.e., three times every 24 hours).
- the balance device is at least as safe as that of drip infusion systems. After a short training period, the staff of an intensive care unit may handle the device without experiencing any problems.
- the present balance device and method avoid the risks of a manual balance procedure and its associated costs. Even if two devices are used in parallel, costs are dramatically lower than those of conventional treatment modes (hemodialysis and mechanical hemofiltration).
- the method and device may, with minor modifications, also be used for different fluid balance problems such as forced diuresis for the treatment of intoxification, gut lavage, arteriovenous plasma filtration and continuous cyclic peritoneal dialysis, as well as in chemical or technical processes.
- FIG. 1 is a side elevational view of a double-beam balance embodiment of the subject invention
- FIG. 2 is an enlarged view of a tube clamp included in FIG. 1;
- FIG. 3 is a side elevational view of a spring balance embodiment of the subject invention.
- FIG. 4 is a side elevational view of another double-beam balance embodiment of the subject invention.
- FIG. 5 is an enlarged view showing a detail of one of the beams included in FIG. 4;
- FIG. 6a is an enlarged view showing a tube clamp included in FIG. 4 in an open position
- FIG. 6b is an enlarged view showing the tube clamp of FIG. 6a in a closed position.
- FIG. 1 there is shown a vertical stand 1 having a base 2, and horizontal upper and lower cross beams 3 and 4, respectively, which are pivotally mounted on the stand 1 by roller bearings 5 and 6, respectively.
- the ends 3b and 4b of the upper and lower beams 3 and 4 have joints 8 and 9 which are connected by a rod 7.
- a hook 3a is provided at the end of the upper beam 3 opposite the end 3b, and a substitution bag 10 is suspended from the hook 3a.
- a graduated container 11 is similarly suspended from a hook 4a provided at the end of the lower beam 4 opposite the end 4b, and the graduated container 11 is adapted to take up filtrate.
- An infusion line depends from the bag 10 and enters a drip chamber 14 connected to a conduit or tube 12.
- a tube or conduit 13 leading from a hemofilter is mounted on a stand (not shown) in such a manner as to be adjustable and hang freely in a relatively wide opening of the graduated container 11.
- a tube clamp including a clamp board 21 over which the tube 12 is extended through a pair of guides 19 and 20.
- the clamp board 21 may be mounted horizontally as shown, for example, in FIG. 2, or may be mounted vertically.
- a single-armed lever 15 has a first end which is pivotally connected with the connecting rod 7 via a pivot pin 17. The other end of the lever 15 is secured to or cooperates with a clamping bracket 18 which is mounted on the stand 1 by means of a pivot pin 16.
- the lever 15 may be fabricated from spring steel or, alternatively, another clamping mechanism may be used, e.g., a mechanism having a vertical tube bed as well as a horizontally directed clamping pin which cooperates with a movable vertical arm of the bracket 18.
- a movable vertical arm may be connected with the bracket 18 at the pivot pin 16 via a torque spring in a Teflon® chamber. This optimizes the leverage for the clamping function.
- a hook 22 is provided on the lower cross beam 4, and a counterweight 23 for the substitution bag 10 is suspended from the hook 22.
- an extra weight 24 is adjustably positioned on a screw thread 25 forming an extension of the lower beam 4. It is therefore possible to adjust the moment or torque precisely to the point where the drip rate from the substitution bag 10 equals the drip rate of the filtrate.
- the tube carrying the filtrate is mounted above the filtrate container 11, and the tube clamp 18,21 is adjusted by means of the adjusting weight 24.
- the negative balance container 26 is filled with water to the desired range.
- the tube clamp 18,21 then remains closed until the amount of filtrate corresponds exactly to the amount of fluid in the negative balance container 26.
- the device thereupon operates in a steady state condition moving the mass point slowly from the upper beam 3 to the lower beam 4. If a continuous negative balance is desired, a drip infusion tube mounted on the vertical stand 1 and connected with a source 26a of an appropriate fluid such as water is led into the negative balance container 26.
- the drip infusion rate which may be set by a valve on the drip infusion tube, then determines the negative balance.
- the device may be constructed using a single beam, and the substitution bag 10 may then be bridged by a frame which carries a mounting pin for the filtrate container 11.
- FIG. 3 An alternative embodiment, which is shown in FIG. 3, includes a hanging double frame unit having an outer frame 30 and an inner frame 31.
- the counterweight 23 of FIG. 1 is replaced by a biasing element 32 such as a spring balance or a pneumatic cylinder provided between the frames 30 and 31.
- the substitution bag 10 and the filtrate container 11 are suspended from the inner frame 31.
- the movement of frames 30 and 31 relative to one another may be used to regulate the clamping bracket 18.
- a scissors-like or collapsible lever arrangement 33 is provided in order to transfer the frame movements to the clamping bracket 18.
- a negative balance may be effected using a roller arrangement which lifts the inner frame 31 when the weight is increased by addition of a negative balance container (not shown).
- the device of FIG. 3 may be hung from the ceiling via a hook 34.
- FIG. 4 shows another embodiment of a doublebeam balance according to the invention being applied for continuous arterio-venous hemofiltration of a patient P.
- the balance of FIG. 4 generally resembles that of FIG. 1 but differs therefrom in certain respects.
- FIG. 4 illustrates how a balance in accordance with the invention is connected with a patient such as the patient P.
- the patient P is connected to a hemofilter 36 by means of a tube 35 leading into and out of the hemofilter 36.
- the tube 35 has a first end which is inserted in an artery of the patient P and a second end which is inserted in a vein of the patient P.
- the tube 35 and hemofilter 36, together with the circulatory system of the patient P, then define a circulatory path for the patient's blood.
- blood rich in metabolic wastes enters the hemofilter 36 on the right while filtered blood leaves the hemofilter 36 on the left.
- a portion of the blood is withdrawn from the hemofilter 36, and hence from the circulatory path, as filtrate. This is indicated by the downwardly pointing arrow adjacent to the hemofilter 36.
- the filtrate is conducted to the filtrate container 11 by means of the filtrate tube or line 13 which is connected with the hemofilter 36.
- the portion of the blood removed from circulation as filtrate is partially or entirely made up by the substitution fluid as indicated by the arrow adjacent to the substitution fluid tube or line 12 leading away from the substitution bag 10.
- the end of the substitution fluid tube 12 remote from the substitution bag 10 is hooked into the circulatory tube 35 downstream of the hemofilter 36, that is, the substitution bag 10 is connected for hemofiltration in a postdilution mode.
- the substitution bag 10 is arranged at a height sufficient to overcome the mean arterial blood pressure, the end of the substitution fluid tube 12 remote from the substitution bag 10 may be hooked into the circulatory tube 35 upstream of the hemofilter 36, i.e., the substitution bag 10 may be connected for hemofiltration in a predilution mode.
- Treatments (B)-(D) are all performed mechanically which has the disadvantage of causing damage to the blood. Furthermore, while the natural kidney operates continuously, each of the treatments (A)-(D) is intermittent.
- the dialysis fluid which is used to wash out metabolic waste products and excess water, must be prepared from purified water, i.e., water obtained from an ion exchange column or by reverse osmosis, and a salt concentrate. This fluid must then be monitored for salt content, i.e., conductivity, and temperature. Due to the high pressures involved, a blood leak detector also is mandatory.
- treatments (E) and (F), namely, continuous ambulatory peritoneal dialysis and continuous arterio-venous hemofiltration, are continuous processes.
- treatments (E) and (F) have the further advantage that they can be performed without incurring great technical expense. This is particularly important for continuous arterio-venous hemofiltration, or CAVH, which is currently restricted mainly to patients suffering from acute renal failure within a syndrome of multiple organ failure. The reason is that such patients are generally confined in intensive care units for which cost reduction is a major consideration. Reduced technical expense is less of a factor for continuous ambulatory peritoneal dialysis, or CAPD, because the patient generally performs this procedure himself or herself.
- CAVH blood withdrawn from a patient's artery is conducted through a small hemofilter and then introduced into one of the patient's veins. While mechanical pumps are used to circulate the blood in mechanical hemodialysis, hemofiltration and hemodiafiltration, CAVH employs the patient's own heart for blood circulation, i.e., 1 to 2% of the blood pumped by the heart. Consequently, pressure monitoring as in the mechanically driven blood purification techniques is unnecessary in CAVH because there is no risk of air embolism (all pressures are above atmospheric pressure).
- CAVH is less effective than intermittent mechanical hemofiltration when considered on an hourly basis, it can be continuously used 24 hours per day since there are no mechanical pumps which damage the blood as in mechanical purification techniques. Accordingly, on a weekly basis, CAVH is more effective than the three weekly treatments of intermittent mechanical hemofiltration normally used in cases of terminal chronic renal failure.
- CAVH has an additional advantage worth mentioning.
- patients who have circulatory problems which are characterized by rapid fluid loss and thereby prevent treatment using conventional intermittent blood purification techniques.
- Such patients are, however, treatable by means of CAVH.
- the balance device of the invention eliminates the need for manual balancing during CAVH thereby greatly reducing the risk of an imbalance.
- a significant advantage of the balance device is that the balancing system is mechanical so that a balance is obtained purely by gravity without employing a source of external power such as electricity.
- the linkage, i.e., the lever 15 or lever arrangement 33, between the balancing system and the clamping bracket 18 is mechanical. Again, this allows the clamping bracket 18 to be operated without an external source of power.
- FIG. 4 illustrates that the flow of fluid to and from the balance device of the invention may likewise occur without an external power source.
- the balance device is designed such that the substitution bag 10 is supported at a level above, and the filtrate container 11 is supported at a level below, the hemofilter 36. Fluid flow from the substitution bag 10 to the patient P lying at the level of the hemofilter 36 can therefore proceed entirely by gravity without any mechanical assist, and the substitution tube 12 is correspondingly devoid of pumps. Similarly, fluid flow from the hemofilter 36 to the filtrate container 11 is able to take place by gravity, and the filtrate tube 13 is accordingly also devoid of pumps. In practice, the blood pressure of the patient P will assist in conveying the filtrate from the hemofilter 36 to the filtrate container 11.
- the balance device of FIG. 4 differs from that of FIG. 1 in certain respects.
- One difference between the balance devices is that the clamp board 21 in FIG. 4 is mounted vertically rather than horizontally.
- the counterweight in FIG. 4 is constituted by or integrated within the connecting rod 7 which may, for example, have a square cross section.
- the balance device of FIG. 1 In the balance device of FIG. 1, a negative balance is achieved via the extra container 26. As illustrated in FIG. 5, the balance device of FIG. 4 employs a different system for obtaining a negative balance.
- FIG. 5 shows that the left-hand arm of the lower beam 4, which supports the filtrate container 11, is formed with a series of notches 38.
- the filtrate container 11 is carried by a bar 37 having an enlarged head 39.
- the head 39 is provided with a protuberance 40 which is designed to be received in the notches 38.
- This arrangement permits the filtrate container 11 to be positioned at any of a plurality of preselected locations along the lower beam 4.
- Each of the preselected locations or notches 38 corresponds to a specific negative balance including one notch 38 which corresponds to zero negative balance.
- the positions of the notches 38 may, for example, be selected in such a manner as to enable the negative balance to be changed from 0 to -2 liters in increments of 0.5 liter.
- FIG. 5 also illustrates the relationship between negative balance and the positions of the notches 38 in the form of a plot of liters of filtrate per unit of substitution fluid versus length of lever arm.
- the number of liters of filtrate per unit of substitution fluid is plotted on the ordinate and represents the negative balance while the length of the lever arm is plotted on the abscissa and represents the positions of the notches 38. It will be observed that the relationship between negative balance and positions of the notches 38 is hyperbolic.
- the balance devices of FIGS. 1 and 4 operate on the principle that the sum of the products of moment arm and weight is the same for the upper beam 3 and the lower beam 4.
- the positions of the notches 38 are accordingly calculated from the law of moments so as to maintain the products of moment arm and weight constant as seen in the plot of FIG. 5.
- the system of FIG. 1 for obtaining a negative balance may be combined with that of FIG. 4.
- the extra container 26 of FIG. 1 may be suspended below the connecting rod 7 of FIG. 4 while the source 26a of negative balance fluid, as well as the drip infusion tube, shown in FIG. 1 may be mounted on the stand 1 of FIG. 4.
- the balance device of FIG. 4 is further provided with a security arrangement 41 which automatically terminates the flow of filtrate to the filtrate container 11 in the event that the substitution bag becomes empty and this goes unnoticed by the attendant or attendants.
- the security arrangement 41 is illustrated in FIGS. 6a and 6b.
- the security arrangement 41 is seen to include a support or bracket 42 which is arranged below the lower beam 4 and has a pair of guides 43 and 44 for the filtrate tube 13. Two spaced pins 46 are secured to the bracket 42 and underlie a segment of that portion of the filtrate tube 13 which is located between the guides 43,44.
- the security arrangement 41 further includes a torsion spring 45 which is mounted on a peg 47 projecting from the stand 1.
- the torsion spring 45 has an upper and a lower leg, and the upper leg is located adjacent to the underside of the lower beam 4.
- the lower leg of the torsion spring 45 is arranged such that the end of the lower leg is disposed above and adjacent to the segment of the filtrate tube 13 between the pins 46.
- the amount of filtrate required to cause clamping of the filtrate tube 13 after the substitution bag 10 has been emptied is relatively small. For instance, 160-200 ml of overflow of filtrate may be required to cause clamping of the filtrate tube 13 when the negative balance is zero. Generally, the amount of overflow filtrate will increase somewhat with, and in proportion to, increasing negative balance.
- a graduated plastic container 48 e.g., a 20 ml syringe, having an outlet which can be closed may be mounted at the discharge end of the filtrate tube 13. By closing the outlet of the container 48 for a predetermined interval and measuring the amount of filtrate which enters the container 48, it is then possible to determine the rate of filtration.
- a commercial infusion control unit may be used instead of the simple plastic container 48.
- a weight transducer is interposed between the substitution bag 10 and the hook from which it is suspended.
- the weight of the transducer may be compensated for by an appropriate counterweight, e.g., a 400 g counterweight.
- an appropriate counterweight e.g. 400 g counterweight.
- Such an arrangement permits the amount of substitution fluid which has been used, as well as the amount of fluid being filtered per unit of time, to be electronically calculated and displayed on a screen.
- an alarm can be programmed to be activated when a preselected quantity, e.g., 4.5 liters, of substitution fluid has been discharged into the patient P.
- this arrangement makes it possible to obtain a continuous balance display for control purposes.
- the substitution fluid is not pumped to the balancing system. Rather, a vessel such as the substitution bag 10 containing the substitution fluid is placed on the balancing system. Generally, the amount of substitution fluid in the vessel will be equal to that required for one exchange, e.g., 4.5 liters.
- the accuracy of the balance device according to the invention was ⁇ 10 ml for a 4.5 liter exchange performed with zero negative balance. With a negative balance of -2 liters, the accuracy was better than ⁇ 20 ml for an exchange cycle.
- the method and device of the invention enable the simplicity of CAVH to be preserved while at the same time eliminating the need for risky manual balancing. Furthermore, the method and device are capable of maintaining sterility at relatively little expense as is desirable for single-use systems. The method and device according to the invention also enable a high degree of safety to be achieved and may be readily used by the nursing staff of an intensive care unit following brief instruction.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Centrifugal Separators (AREA)
- Cyclones (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3213390 | 1982-04-10 | ||
DE19823213390 DE3213390A1 (de) | 1982-04-10 | 1982-04-10 | Vorrichtung zur bilanzierung des fluessigkeitsaustausches bei haemofiltrationen |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06820442 Continuation | 1986-01-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
US4894150A true US4894150A (en) | 1990-01-16 |
Family
ID=6160695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/205,618 Expired - Fee Related US4894150A (en) | 1982-04-10 | 1988-06-02 | Mechanical device for simplifying fluid balance in hemofiltration |
Country Status (5)
Country | Link |
---|---|
US (1) | US4894150A (de) |
EP (1) | EP0093259B1 (de) |
JP (1) | JPH0720491B2 (de) |
AT (1) | ATE27549T1 (de) |
DE (2) | DE3213390A1 (de) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998035710A3 (en) * | 1997-02-14 | 1998-11-19 | Vasca Inc | Hemofiltration system |
US6554789B1 (en) | 1997-02-14 | 2003-04-29 | Nxstage Medical, Inc. | Layered fluid circuit assemblies and methods for making them |
US6579253B1 (en) | 1997-02-14 | 2003-06-17 | Nxstage Medical, Inc. | Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge |
US6595943B1 (en) | 1997-02-14 | 2003-07-22 | Nxstage Medical, Inc. | Systems and methods for controlling blood flow and waste fluid removal during hemofiltration |
US6638478B1 (en) * | 1997-02-14 | 2003-10-28 | Nxstage Medical, Inc. | Synchronized volumetric fluid balancing systems and methods |
US6638477B1 (en) | 1997-02-14 | 2003-10-28 | Nxstage Medical, Inc. | Fluid replacement systems and methods for use in hemofiltration |
US6673314B1 (en) | 1997-02-14 | 2004-01-06 | Nxstage Medical, Inc. | Interactive systems and methods for supporting hemofiltration therapies |
US6706007B2 (en) * | 2000-12-29 | 2004-03-16 | Chf Solutions, Inc. | Feedback control of ultrafiltration to prevent hypotension |
US20040133145A1 (en) * | 2002-12-20 | 2004-07-08 | Hospal International Marketing Management Snc | Device and process for extracorporeal treatment by citrate anticoagulant |
US20040243048A1 (en) * | 1997-02-14 | 2004-12-02 | Brugger James M. | Registration of fluid circuit components in a blood treatment device |
US20040243047A1 (en) * | 1997-02-14 | 2004-12-02 | Brugger James M. | Single step fluid circuit engagement device and method |
US6830553B1 (en) | 1997-02-14 | 2004-12-14 | Nxstage Medical, Inc. | Blood treatment systems and methods that maintain sterile extracorporeal processing conditions |
US20040267183A1 (en) * | 2003-06-25 | 2004-12-30 | Hospal International Marketing Management Snc. | Extracorporeal treatment device with automatic emptying of waste bag |
US20050000868A1 (en) * | 2002-09-27 | 2005-01-06 | William Weigel | Volumetric fluid balance control for extracorporeal blood treatment |
US20050045548A1 (en) * | 1997-02-14 | 2005-03-03 | James Brugger | Hemofiltration systems and methods that maintain sterile extracorporeal processing conditions |
US20070038191A1 (en) * | 2003-01-15 | 2007-02-15 | Burbank Jeffrey H | Waste balancing for extracorporeal blood treatment systems |
US20080149551A1 (en) * | 1999-11-29 | 2008-06-26 | Nxstage Medical, Inc. | Blood treatment apparatus |
US8235931B2 (en) | 2003-01-15 | 2012-08-07 | Nxstage Medical, Inc. | Waste balancing for extracorporeal blood treatment systems |
WO2018017623A1 (en) | 2016-07-18 | 2018-01-25 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US9931452B2 (en) | 2012-03-21 | 2018-04-03 | Gambro Lundia Ab | Treatment solution delivery in an extracorporeal blood treatment apparatus |
WO2018112210A1 (en) | 2016-12-14 | 2018-06-21 | Nxstage Medical, Inc. | Treatment fluid multi-stream blood warmer |
US20180207361A1 (en) * | 2015-07-21 | 2018-07-26 | B. Braun Melsungen Ag | Actuating device for administering a bolus |
WO2018145035A1 (en) | 2017-02-03 | 2018-08-09 | Nxstage Medical, Inc. | Multiple mode treatment devices methods and systems |
EP3539586A1 (de) | 2014-10-10 | 2019-09-18 | NxStage Medical Inc. | Flussausgleichsvorrichtungen, verfahren und systeme dafür |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895558A (en) * | 1985-07-15 | 1990-01-23 | University Of Queensland | Autologous plasma delipidation using a continuous flow system |
US4994026A (en) * | 1988-08-31 | 1991-02-19 | W. R. Grace & Co.-Conn. | Gravity flow fluid balance system |
JP3568953B2 (ja) | 1993-07-30 | 2004-09-22 | アルバ・インターナショナル・プロプライアタリ・リミテッド | 血漿脱脂肪システム |
AUPN030794A0 (en) | 1994-12-22 | 1995-01-27 | Aruba International Pty Ltd | Discontinuous plasma or serum delipidation |
US20090017069A1 (en) | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
EP2368565B1 (de) * | 2003-07-03 | 2015-06-24 | HDL Therapeutics, Inc. | Anreicherung von pre-beta high density Lipoproteinen |
US7393826B2 (en) | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
DE102005031694B3 (de) * | 2005-07-05 | 2007-01-11 | Pvb Critical Care Gmbh | Liquor-Drainagevorrichtung |
CN111868232B (zh) | 2017-11-22 | 2024-05-28 | Hdl治疗公司 | 用于对血浆处理***的流体回路进行灌注的***和方法 |
WO2019133358A2 (en) | 2017-12-28 | 2019-07-04 | Hdl Therapeutics, Inc. | Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US75146A (en) * | 1868-03-03 | truex | ||
US1167941A (en) * | 1913-12-12 | 1916-01-11 | Sargent & Co | Scale-beam. |
US2026290A (en) * | 1933-04-08 | 1935-12-31 | Asahi Koki Seisakusho Kk | Weighing scale |
US3242924A (en) * | 1963-10-11 | 1966-03-29 | Scientific Industries | Infusion monitoring device with snap action cut-off means |
US3299977A (en) * | 1965-04-07 | 1967-01-24 | Butler Bin Company | Dual range weighing scale |
US3425415A (en) * | 1966-05-02 | 1969-02-04 | Iit Res Inst | Controlled infusion system |
DE1566680A1 (de) * | 1967-09-13 | 1971-01-14 | Dr Med Dieter Wiebecke | Automatischer Transfusions- und Infusions-Unterbrecher |
US3949744A (en) * | 1973-09-04 | 1976-04-13 | Ellis Whiteside Clarke | Apparatus for the administration of liquids |
DE2629717A1 (de) * | 1976-07-02 | 1978-01-05 | Fresenius Chem Pharm Ind | Vorrichtung zur steuerung des fluessigkeitsausgleichs bei der haemodiafiltration |
FR2397197A1 (en) * | 1978-11-03 | 1979-02-09 | Sodip Sa | Extracorporeal blood purificn. - by simultaneous haemodialysis and haemo-filtration with incorporated flow ewuilibrantion |
US4204957A (en) * | 1975-11-21 | 1980-05-27 | Sartorius Membranfilter Gmbh | Artificial kidney |
US4240408A (en) * | 1977-12-10 | 1980-12-23 | Dr. Eduard Fresenius Chemisch-Pharmazeutische Industrie Kg, Apparatebau Kg | Peritoneal dialysis apparatus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5498096A (en) * | 1978-01-19 | 1979-08-02 | Nissho Kk | Artificial filter type kidney device |
JPS5519135A (en) * | 1978-07-27 | 1980-02-09 | Terumo Corp | Vessel of chemicals* etc* used for filtration type artificial kidney device |
-
1982
- 1982-04-10 DE DE19823213390 patent/DE3213390A1/de not_active Withdrawn
-
1983
- 1983-03-22 AT AT83102812T patent/ATE27549T1/de not_active IP Right Cessation
- 1983-03-22 DE DE8383102812T patent/DE3371868D1/de not_active Expired
- 1983-03-22 EP EP83102812A patent/EP0093259B1/de not_active Expired
- 1983-04-09 JP JP58061567A patent/JPH0720491B2/ja not_active Expired - Lifetime
-
1988
- 1988-06-02 US US07/205,618 patent/US4894150A/en not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US75146A (en) * | 1868-03-03 | truex | ||
US1167941A (en) * | 1913-12-12 | 1916-01-11 | Sargent & Co | Scale-beam. |
US2026290A (en) * | 1933-04-08 | 1935-12-31 | Asahi Koki Seisakusho Kk | Weighing scale |
US3242924A (en) * | 1963-10-11 | 1966-03-29 | Scientific Industries | Infusion monitoring device with snap action cut-off means |
US3299977A (en) * | 1965-04-07 | 1967-01-24 | Butler Bin Company | Dual range weighing scale |
US3425415A (en) * | 1966-05-02 | 1969-02-04 | Iit Res Inst | Controlled infusion system |
DE1566680A1 (de) * | 1967-09-13 | 1971-01-14 | Dr Med Dieter Wiebecke | Automatischer Transfusions- und Infusions-Unterbrecher |
US3949744A (en) * | 1973-09-04 | 1976-04-13 | Ellis Whiteside Clarke | Apparatus for the administration of liquids |
US4204957A (en) * | 1975-11-21 | 1980-05-27 | Sartorius Membranfilter Gmbh | Artificial kidney |
DE2629717A1 (de) * | 1976-07-02 | 1978-01-05 | Fresenius Chem Pharm Ind | Vorrichtung zur steuerung des fluessigkeitsausgleichs bei der haemodiafiltration |
US4240408A (en) * | 1977-12-10 | 1980-12-23 | Dr. Eduard Fresenius Chemisch-Pharmazeutische Industrie Kg, Apparatebau Kg | Peritoneal dialysis apparatus |
FR2397197A1 (en) * | 1978-11-03 | 1979-02-09 | Sodip Sa | Extracorporeal blood purificn. - by simultaneous haemodialysis and haemo-filtration with incorporated flow ewuilibrantion |
Non-Patent Citations (4)
Title |
---|
Jensen, M. W. et al, "The Examination of Weighing Equipment", N.B.S. Handbook 94, Mar. 1, 1965, pp. 154-155. |
Jensen, M. W. et al, The Examination of Weighing Equipment , N.B.S. Handbook 94, Mar. 1, 1965, pp. 154 155. * |
Quellhorst, E. "Hamofiltration . . . " Medizintechnik, 101 Jg., 5/1981 pp. 224, 126-128. |
Quellhorst, E. Hamofiltration . . . Medizintechnik, 101 Jg., 5/1981 pp. 224, 126 128. * |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7473238B2 (en) | 1997-02-14 | 2009-01-06 | Nxstage Medical, Inc. | Hemofiltration systems and methods that maintain sterile extracorporeal processing conditions |
US6589482B1 (en) | 1997-02-14 | 2003-07-08 | Nxstage Medical, Inc. | Extracorporeal circuits for performing hemofiltration employing pressure sensing without an air interface |
US6579253B1 (en) | 1997-02-14 | 2003-06-17 | Nxstage Medical, Inc. | Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge |
US20080306426A9 (en) * | 1997-02-14 | 2008-12-11 | Brugger James M | Blood flow control in a blood treatment device |
US7776001B2 (en) | 1997-02-14 | 2010-08-17 | Nxstage Medical Inc. | Registration of fluid circuit components in a blood treatment device |
US6638478B1 (en) * | 1997-02-14 | 2003-10-28 | Nxstage Medical, Inc. | Synchronized volumetric fluid balancing systems and methods |
US6638477B1 (en) | 1997-02-14 | 2003-10-28 | Nxstage Medical, Inc. | Fluid replacement systems and methods for use in hemofiltration |
US6673314B1 (en) | 1997-02-14 | 2004-01-06 | Nxstage Medical, Inc. | Interactive systems and methods for supporting hemofiltration therapies |
US20090012442A9 (en) * | 1997-02-14 | 2009-01-08 | Brugger James M | Registration of fluid circuit components in a blood treatment device |
WO1998035710A3 (en) * | 1997-02-14 | 1998-11-19 | Vasca Inc | Hemofiltration system |
US20040243048A1 (en) * | 1997-02-14 | 2004-12-02 | Brugger James M. | Registration of fluid circuit components in a blood treatment device |
US20040243047A1 (en) * | 1997-02-14 | 2004-12-02 | Brugger James M. | Single step fluid circuit engagement device and method |
US20040243049A1 (en) * | 1997-02-14 | 2004-12-02 | Brugger James M. | Blood-contactless measurement of arterial pressure |
US6830553B1 (en) | 1997-02-14 | 2004-12-14 | Nxstage Medical, Inc. | Blood treatment systems and methods that maintain sterile extracorporeal processing conditions |
US6554789B1 (en) | 1997-02-14 | 2003-04-29 | Nxstage Medical, Inc. | Layered fluid circuit assemblies and methods for making them |
US20040267184A1 (en) * | 1997-02-14 | 2004-12-30 | Burbank Jeffrey H. | Measurement of fluid pressure in a blood treatment device |
US6595943B1 (en) | 1997-02-14 | 2003-07-22 | Nxstage Medical, Inc. | Systems and methods for controlling blood flow and waste fluid removal during hemofiltration |
US20050045548A1 (en) * | 1997-02-14 | 2005-03-03 | James Brugger | Hemofiltration systems and methods that maintain sterile extracorporeal processing conditions |
US20050113734A1 (en) * | 1997-02-14 | 2005-05-26 | Brugger James M. | Network-based extracorporeal blood treatment information system |
US20050113735A1 (en) * | 1997-02-14 | 2005-05-26 | Brugger James M. | Blood flow control in a blood treatment device |
US6955655B2 (en) | 1997-02-14 | 2005-10-18 | Nxstage Medical, Inc. | Hemofiltration system |
US7147613B2 (en) | 1997-02-14 | 2006-12-12 | Nxstage Medical, Inc. | Measurement of fluid pressure in a blood treatment device |
US20080149551A1 (en) * | 1999-11-29 | 2008-06-26 | Nxstage Medical, Inc. | Blood treatment apparatus |
US7780619B2 (en) | 1999-11-29 | 2010-08-24 | Nxstage Medical, Inc. | Blood treatment apparatus |
US6706007B2 (en) * | 2000-12-29 | 2004-03-16 | Chf Solutions, Inc. | Feedback control of ultrafiltration to prevent hypotension |
US20050000868A1 (en) * | 2002-09-27 | 2005-01-06 | William Weigel | Volumetric fluid balance control for extracorporeal blood treatment |
US7112273B2 (en) * | 2002-09-27 | 2006-09-26 | Nxstage Medical, Inc. | Volumetric fluid balance control for extracorporeal blood treatment |
US20040133145A1 (en) * | 2002-12-20 | 2004-07-08 | Hospal International Marketing Management Snc | Device and process for extracorporeal treatment by citrate anticoagulant |
US7351218B2 (en) * | 2002-12-20 | 2008-04-01 | Gambro Lundia Ab | Device and process for extracorporeal treatment by citrate anticoagulant |
US7686778B2 (en) | 2003-01-15 | 2010-03-30 | Nxstage Medical, Inc. | Waste balancing for extracorporeal blood treatment systems |
US8235931B2 (en) | 2003-01-15 | 2012-08-07 | Nxstage Medical, Inc. | Waste balancing for extracorporeal blood treatment systems |
US20070038191A1 (en) * | 2003-01-15 | 2007-02-15 | Burbank Jeffrey H | Waste balancing for extracorporeal blood treatment systems |
US20040267183A1 (en) * | 2003-06-25 | 2004-12-30 | Hospal International Marketing Management Snc. | Extracorporeal treatment device with automatic emptying of waste bag |
US7588722B2 (en) | 2003-06-25 | 2009-09-15 | Gambro Lundia Ab | Extracorporeal treatment device with automatic emptying of waste bag |
US9931452B2 (en) | 2012-03-21 | 2018-04-03 | Gambro Lundia Ab | Treatment solution delivery in an extracorporeal blood treatment apparatus |
US11020517B2 (en) | 2012-03-21 | 2021-06-01 | Gambro Lundia Ab | Treatment solution delivery in an extracorporeal blood treatment apparatus |
US11850341B2 (en) | 2014-10-10 | 2023-12-26 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US10835659B2 (en) | 2014-10-10 | 2020-11-17 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US11406744B2 (en) | 2014-10-10 | 2022-08-09 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
EP3539586A1 (de) | 2014-10-10 | 2019-09-18 | NxStage Medical Inc. | Flussausgleichsvorrichtungen, verfahren und systeme dafür |
US10525182B2 (en) | 2014-10-10 | 2020-01-07 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US10835658B2 (en) | 2014-10-10 | 2020-11-17 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US10835657B2 (en) | 2014-10-10 | 2020-11-17 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US10869958B2 (en) | 2014-10-10 | 2020-12-22 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US20180207361A1 (en) * | 2015-07-21 | 2018-07-26 | B. Braun Melsungen Ag | Actuating device for administering a bolus |
US10898635B2 (en) | 2016-07-18 | 2021-01-26 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
WO2018017623A1 (en) | 2016-07-18 | 2018-01-25 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
EP4052737A1 (de) | 2016-07-18 | 2022-09-07 | NxStage Medical Inc. | Flussausgleichsvorrichtungen, verfahren und systeme dafür |
US11607482B2 (en) | 2016-07-18 | 2023-03-21 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
US11752249B2 (en) | 2016-12-14 | 2023-09-12 | Nxstage Medical, Inc. | Treatment fluid multi-stream blood warmer |
WO2018112210A1 (en) | 2016-12-14 | 2018-06-21 | Nxstage Medical, Inc. | Treatment fluid multi-stream blood warmer |
WO2018145035A1 (en) | 2017-02-03 | 2018-08-09 | Nxstage Medical, Inc. | Multiple mode treatment devices methods and systems |
Also Published As
Publication number | Publication date |
---|---|
JPH0720491B2 (ja) | 1995-03-08 |
DE3371868D1 (en) | 1987-07-09 |
DE3213390A1 (de) | 1983-10-20 |
EP0093259B1 (de) | 1987-06-03 |
ATE27549T1 (de) | 1987-06-15 |
JPS58200752A (ja) | 1983-11-22 |
EP0093259A1 (de) | 1983-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4894150A (en) | Mechanical device for simplifying fluid balance in hemofiltration | |
US8262602B2 (en) | Remote exchange peritoneal dialysis | |
US4560472A (en) | Peritoneal dialysis apparatus | |
US6471872B2 (en) | Hemofiltration system and method based on monitored patient parameters | |
AU754841B2 (en) | Dialysis machine, in particular for home use | |
USRE38869E1 (en) | Extracorporeal circuit for peripheral vein fluid removal | |
US6824524B1 (en) | Tubing for the extracorporal purification of the blood and use thereof | |
CA1042747A (en) | Cardiopulmonary bypass system | |
US5344568A (en) | Hemofiltration system and method | |
US8562823B2 (en) | Dynamic weight balancing of flow in kidney failure treatment systems | |
JP3677046B2 (ja) | 精製パルス腹膜透析のための装置 | |
US5895571A (en) | Separable hemodialysis system connected by a movable arm | |
RU2020970C1 (ru) | Искусственная почка | |
WO2009148987A2 (en) | Remote exchange peritoneal dialysis | |
JPH04227267A (ja) | 代替液を調製するための方法及び装置 | |
US20020023879A1 (en) | Method and system for hemodialysis for use in a non-clinical environment | |
Ronco et al. | Current technology for continuous renal replacement therapies | |
DK172894B1 (da) | Hæmodialyseapparat | |
Dunea | Peritoneal dialysis and hemodialysis | |
Schurek et al. | Continuous arteriovenous hemofiltration: improvement in the handling of fluid balance and heparinization | |
Martin et al. | Nursing management of continuous renal replacement therapy | |
Sodemann et al. | Automated fluid balance in continuous hemodialysis with blood safety module BSM 22/VPM | |
Blumenthal et al. | Inflow time and recirculation in single-needle hemodialysis | |
JPH06233813A (ja) | 血液浄化装置 | |
US5115682A (en) | Coronary artery graft flow-meter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20020116 |